Nuclear Factor-κB Decoy Oligodeoxynucleotide Attenuates Cartilage Resorption In Vitro

• Published in: Bioengineering (Basel) Vol. 11; no. 1; p. 46
• Main Authors: Nemoto, Hitoshi, Sakai, Daisuke, Watson, Deborah, Masuda, Koichi
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.01.2024
• Subjects: Antibiotics; Arthritis; Asthma; Back pain; Cartilage; Chondrocytes; Clinical trials; Cytokines; Cytotoxicity; decoy oligodeoxynucleotide; Degradation; Health aspects; Inflammation; Interleukin 1; Kinases; Matrix metalloproteinase; Methods; NF-κB protein; nuclear factor-κb; Oligodeoxynucleotides; Pharmacology; Proteins; Proteoglycans; resorption; Surgery, Plastic; Synthesis; Toxicity; Transcription factors; Transplantation; Transplants & implants; Tumor necrosis factor-TNF; Wound healing; United States; United States > US; Japan; nuclear factor-κb; decoy oligodeoxynucleotide; resorption; cartilage
• ISSN: 2306-5354; 2306-5354
• DOI: 10.3390/bioengineering11010046

Cartilage harvest and transplantation is a common surgery using costal, auricular, and septal cartilage for craniofacial reconstruction. However, absorption and warping of the cartilage grafts can occur due to inflammatory factors associated with wound healing. Transcription factor nuclear factor-κB (NF-κB) is activated by the various stimulation such as interleukin-1 (IL-1), and plays a central role in the transactivation of this inflammatory cytokine gene. Inhibition of NF-κB may have anti-inflammatory effects. The aim of this study was to explore the potential of an NF-κB decoy oligodeoxynucleotide (Decoy) as a chondroprotective agent. Safe and efficacious concentrations of Decoy were assessed using rabbit nasal septal chondrocytes (rNSChs) and assays for cytotoxicity, proteoglycan (PG) synthesis, and PG turnover were carried out. The efficacious concentration of Decoy determined from the rNSChs was then applied to human nasal septal cartilage (hNSC) in vitro and analyzed for PG turnover, the levels of inflammatory markers, and catabolic enzymes in explant-conditioned culture medium. Over the range of Decoy conditions and concentrations, no inhibition of PG synthesis or cytotoxicity was observed. Decoy at 10 μM effectively inhibited PG degradation in the hNSC explant, prolonging PG half-life by 63% and decreasing matrix metalloprotease 3 (MMP-3) by 70.7% ( = 0.027). Decoy may be considered a novel chondroprotective therapeutic agent in cartilage transplantation due to its ability to inhibit cartilage degradation due to inflammation cytokines.